Eris Lifesciences Ltd vs Medico Intercontinental Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1357 as of 05 May 15:30 . The P/E Ratio of ERIS Lifesciences Ltd changed from 23.1 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 18.86% over 5 yearsThe P/E Ratio of Medico Intercontinental Ltd changed from 3.2 on March 2021 to 7 on March 2025 . This represents a CAGR of 16.95% over 5 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8207 crore on March 2021 to ₹ 19287 crore on March 2025 . This represents a CAGR of 18.64% over 5 yearsThe Market Cap of Medico Intercontinental Ltd changed from ₹ 8.33 crore on March 2021 to ₹ 35.47 crore on March 2025 . This represents a CAGR of 33.61% over 5 years The revenue of ERIS Lifesciences Ltd for the Dec '25 is ₹ 807.59 crore as compare to the Sep '25 revenue of ₹ 795.5 crore. This represent the growth of 1.52% The revenue of Medico Intercontinental Ltd for the Dec '25 is ₹ 20.19 crore as compare to the Sep '25 revenue of ₹ 20.95 crore. This represent the decline of -3.63% The ebitda of ERIS Lifesciences Ltd for the Dec '25 is ₹ 264.51 crore as compare to the Sep '25 ebitda of ₹ 291.3 crore. This represent the decline of -9.2% The ebitda of Medico Intercontinental Ltd for the Dec '25 is ₹ 1.93 crore as compare to the Sep '25 ebitda of ₹ -0.33 crore. This represent the decline of -684% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 108.83 crore over 7 quarters. This represents a CAGR of 11.79% The net profit of Medico Intercontinental Ltd changed from ₹ 1.08 crore to ₹ -1.68 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of Medico Intercontinental Ltd changed from 5.88 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About Medico Intercontinental Ltd

Medico Intercontinental Limited, formerly known as Intercontinental Leasing & Finance Company Limited was incorporated on August 14, 1984 in Ahmedabad, India.
The Company changed its name to 'Medico Intercontinental Limited' in December, 2018.
The Company is involved in trading of pharmaceutical products. The Company is also providing a platform to all research based bio-pharmaceutical companies reaching their novel and innovative therapies to every part of the globe.
From helping people obtain their medications to using cutting-edge scientific technology to discover new treatments, Medico's entrepreneurial spirit, teamwork-oriented culture and commitment to rare diseases create a unique platform for transforming patient outcomes.
The Company's commitment to changing the course of human health through bold pursuits in science, life-enhancing therapies and a promise to always put patients first across the continents.

FAQs for the comparison of ERIS Lifesciences Ltd and Medico Intercontinental Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Medico Intercontinental Ltd?

Market cap of ERIS Lifesciences Ltd is 18,813 Cr while Market cap of Medico Intercontinental Ltd is 23 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Medico Intercontinental Ltd?

The stock performance of ERIS Lifesciences Ltd and Medico Intercontinental Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Medico Intercontinental Ltd?

As of May 5, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1357.95. On the other hand, Medico Intercontinental Ltd stock price is INR ₹23.29.

How do dividend payouts of ERIS Lifesciences Ltd and Medico Intercontinental Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Medico Intercontinental Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.